The innovative drug concept has seen a surge, with CCHT rising over 8%, Xinghao Pharmaceutical and WBDE rising over 5%, and Tibet Pharmaceutical, REMEGEN, Salubris, Cosunter, and INNOCARE also following suit
The innovative drug concept has seen a surge, with CCHT rising over 8%, Xinghao Pharmaceutical and WBDE rising over 5%, and Tibet Pharmaceutical, REMEGEN, Salubris, Cosunter, and INNOCARE also following suit